Dietary fat modulates the testosterone pharmacokinetics of a new self-emulsifying formulation of oral testosterone undecanoate in hypogonadal men

Journal of Andrology

Volumn 33, Issue 6, 2012, Pages 1282-1290

  Yin, Anthony ^a   Alfadhli, Eman ^a   Htun, Michelle ^a   Dudley, Robert ^c   Faulkner, Sandra ^c   Hull, Laura ^a   Leung, Andrew ^a   Bross, Rachelle ^a,b   Longstreth, James ^c   Swerdloff, Ronald ^a   Wang, Christina ^a,b  

^a Division of Endocrinology   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c Clarus Therapeutics Inc   (United States)

Author keywords

Food effect; Male hypogonadism

Indexed keywords

ANDROSTANOLONE; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CALORIE; CATHETER COMPLICATION; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTACT DERMATITIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG FORMULATION; EYE SWELLING; FAT CONTENT; FAT INTAKE; HEADACHE; HUMAN; HYPEREMIA; HYPOGONADISM; LIQUID CHROMATOGRAPHY; MALE; MEAL; OPEN STUDY; OROPHARYNX PAIN; OTORRHEA; PAIN; PRIORITY JOURNAL; RHINORRHEA; SINGLE DRUG DOSE; SOMNOLENCE; SWELLING; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; DIETARY FATS; DIHYDROTESTOSTERONE; EMULSIONS; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 84874409467     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.112.017020     Document Type: Article

References (14)

1. Attardi BJ, Hild SA, Reel JR. Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity. Endocrinology. 2006;147:3016-3026.
2. Bagchus WM, Hust R, Maris F, Schnabel PG, Houwing NS. Important effect of food on the bioavailability of oral testosterone undecanoate. Pharmacotherapy. 2003;23:319-325.
3. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983;56:1278-1281.
4. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf). 2003;58:710-717.
5. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. J Am Med Assoc. 2008;299:39-52.
6. Gooren LJ. A ten-year safety study of the oral androgen testosterone undecanoate. J Androl. 1994;15:212-215.
7. Hirschhauser C, Hopkinson CR, Sturm G, Coert A. Testosterone undecanoate: a new orally active androgen. Acta Endocrinol (Cph). 1975;80:179-187.
8. Horst HJ, Holtje WJ, DennisM, Coert A, Geelen J, Voigt KD. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wochenschr. 1976;54:875-879.
9. Legros JJ, Meuleman EJ, Elbers JM, Geurts TB, Kaspers MJ, Bouloux PM. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study. Eur J Endocrinol. 2009;160:821-831.
10. Roth MY, Dudley RE, Hull L, Leung A, Christenson P, Wang C, Swerdloff R, Amory JK. Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5areductase by finasteride. Int J Androl. 2011;34:541-547.
11. Schnabel PG, Bagchus W, Lass H, Thomsen T, Geurts TB. The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps. Clin Endocrinol (Oxf). 2007;66:579-585.
12. Shiraishi S, Lee PW, Leung A, Goh VH, Swerdloff RS, Wang C. Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry. Clin Chem. 2008;54:1855-1863.
13. Skakkebaek NE, Bancroft J, Davidson DW, Warner P. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study. Clin Endocrinol (Oxf). 1981;14:49-61.
14. Yin AY, Htun M, Swerdloff RS, Diaz-Arjonilla M, Dudley RE, Faulkner S, Bross R, Leung A, Baravarian S, Hull L, Longstreth JA, Kulback S, Flippo G, Wang C. Re-examination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation. J Androl. 2011;33: 190-201.